James Van Der Beek was mourned by his former Dawson’s Creek co-stars, peers, friends and family when he died on February 11, 2026, following a battle with colorectal cancer. As Hollywood paid tribute ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. When Kulindu Vithanachchi’s phone lit up with an update from the National Science ...
Life’s story may stretch further back than scientists once thought. Some genes found in nearly every organism today were already duplicated before all life shared a common ancestor. By tracking these ...
Achieve Life Sciences is a single-asset microcap centered on cytisinicline, with an accepted NDA and a June 20, 2026, PDUFA. Cytisinicline's α4β2 partial agonism aims to reduce cravings and blunt ...
A Dalai Lama once said that our prime purpose in this life is to help others – and he may have been right. Scientists have found that having a positive impact on other people seems to be a key element ...
CSIR UGC NET December Result: The National Testing Agency (NTA) has officially announced the results for the Joint CSIR UGC NET December 2025 examination on its website. The scorecards were made ...
After two years of layoffs and funding pullbacks, South San Francisco’s life science industry is showing stronger signs of a comeback— though more mega-rounds and less early-stage funding could ...
The National Testing Agency(NTA) will soon publish the CSIR-UGC NET result 2025. Candidates can download the NTA Joint CSIR-UGC NET result at https://csirnet.nta.nic.in/; the examination for the same ...
Chiba, Japan, January 12, 2026—A team at Japan’s National Institutes for Quantum Science and Technology (QST) has published a field-defining Perspective that places the societal payoff of quantum ...
Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...
Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...